Atlantic Bone Screen is a leading CRO (« Contract Research Organization ») specialized in high-quality preclinical evaluation services and non clinical studies, especially in osteoarticular indications, oncology and inflammation.
Created in 2005 by Ronan LE BOT, CEO, Atlantic Bone Screen puts at disposal a unique preclinical platform with a wide range of competitive in-vitro and in-vivo assays as well as ex vivo service (histology, biomarkers analyses and imaging services).
More than 2500 preclinical studies have been conducted by our Team since its creation. Research centers from the most important pharmaceutical and food industries as well as cosmetics and biomaterial companies, from Europe, North America and Asia, have put their trust in Atlantic Bone Screen. The company has many partners and consultants providing complementary services, especially expert CRO’s member of AFSSI French association.
Atlantic Bone Screen is a registered as a service provider for research tax credit “CIR agreement” from the French Ministry of Research.